Please use this identifier to cite or link to this item:
|Title:||Amyloid beta plaque reduction with antibodies crossing the blood brain barrier opened with focused ultrasound in a rabbit model||Authors:||Yiannakou, Marinos
Damianou, Christakis A.
|Keywords:||Alzheimer;Amyloid betaplaque;Αntibody;Βrain;Focused ultrasound;MRI||Category:||Clinical Medicine||Field:||Medical and Health Sciences||Issue Date:||28-Dec-2015||Publisher:||Institute of Electrical and Electronics Engineers Inc.||Source:||15th IEEE International Conference on Bioinformatics and Bioengineering, BIBE 2015; Belgrade; Serbia; 2 November 2015 through 4 November 2015||DOI:||10.1109/BIBE.2015.7367707||Conference:||IEEE International Conference on Bioinformatics and Bioengineering||Abstract:||The main objective of the study was to treat Alzheimer's disease (AD) plaques using focused ultrasound (FUS) induced blood brain barrier (BBB) opening with and without delivery of antibodies in a rabbit model for AD. The animal model was achieved by feeding a high cholesterol diet to rabbits for 4 months. A single spherically focused MRI compatible transducer was used which operated at 1 MHz, had a focal length of 10 cm and diameter of 4 cm. By increasing the number of sessions, the number of plaques decreased (both for antibodies, and without antibodies). This study demonstrated that by opening the BBB, it will be possible to deliver exogenous antibodies to the brain, which eliminates Amyloid β plaques.||URI:||http://ktisis.cut.ac.cy/handle/10488/9113||ISBN:||978-146737983-0||Rights:||© 2015 IEEE.||Type:||Conference Papers|
|Appears in Collections:||Δημοσιεύσεις σε συνέδρια/Conference papers|
Show full item record
Page view(s) 50104
checked on Sep 20, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.